Peer Review reports
From: Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen
| Original Submission | ||
|---|---|---|
| 13 Feb 2024 | Submitted | Original manuscript |
| 2 Mar 2024 | Reviewed | Reviewer Report |
| 4 Mar 2024 | Reviewed | Reviewer Report - Nyasha Chin’Ombe |
| 8 Apr 2024 | Reviewed | Reviewer Report |
| 19 Apr 2024 | Author responded | Author comments - Falasca Katia |
| Resubmission - Version 2 | ||
| 19 Apr 2024 | Submitted | Manuscript version 2 |
| 22 Apr 2024 | Author responded | Author comments - Falasca Katia |
| Resubmission - Version 3 | ||
| 22 Apr 2024 | Submitted | Manuscript version 3 |
| 24 Apr 2024 | Author responded | Author comments - Falasca Katia |
| Resubmission - Version 4 | ||
| 24 Apr 2024 | Submitted | Manuscript version 4 |
| 5 May 2024 | Reviewed | Reviewer Report |
| 22 May 2024 | Reviewed | Reviewer Report |
| 4 Jun 2024 | Author responded | Author comments - Falasca Katia |
| Resubmission - Version 5 | ||
| 4 Jun 2024 | Submitted | Manuscript version 5 |
| 6 Jun 2024 | Author responded | Author comments - Falasca Katia |
| Resubmission - Version 6 | ||
| 6 Jun 2024 | Submitted | Manuscript version 6 |
| 25 Jun 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 25 Jun 2024 | Editorially accepted | |
| 3 Jul 2024 | Article published | 10.1186/s12879-024-09565-w |
You can find further information about peer review here.